Pathogenicity, host responses and implications for management of enterohemorrhagic Escherichia coli O157:H7 infection

被引：26
|
作者：
Ho, Nathan K. [1 ,2 ]
Henry, Aleah C. [3 ]
Johnson-Henry, Kathene [1 ]
Sherman, Philip M. [1 ,2 ]
机构：
[1] Hosp Sick Children, Dept Paediat, Toronto, ON M5G 1X8, Canada
[2] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada
[3] McMaster Univ, Dept Chem Engn, Hamilton, ON L8S 4L7, Canada
来源：
CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY | 2013年 / 27卷 / 05期
关键词：
Escherichia coli; Host response; Irritable bowel syndrome; Pathogenicity; Treatment; HEMOLYTIC-UREMIC SYNDROME; SHIGA-TOXIN; INBORN-ERRORS; IFN-GAMMA; DIARRHEA; PATHOGENESIS; PHOSPHORYLATION; CYTOTOXIN; OUTBREAKS; CHILDREN;
D O I：
10.1155/2013/138673
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Enterohemorrhagic Escherichia coli serotype O157:H7 is a food- and waterborne pathogen that causes significant morbidity and mortality in both developing and industrialized nations. The present review focuses on the history, epidemiology and evolution of the pathogen; provides a mechanistic overview of major virulence factors (including Shiga toxins, locus of enterocyte effacement pathogenicity island and pO157 plasmid); discusses host immune responses to infection; considers available animal models; and provides an overview of current and potential future management considerations.
引用
收藏
页码：281 / 285
页数：5
相关论文
共 50 条
  • [1] All blood, No stool:: enterohemorrhagic Escherichia coli O157:H7 infection
    Yoon, Jang W.
    Hovde, Carolyn J.
    JOURNAL OF VETERINARY SCIENCE, 2008, 9 (03) : 219 - 231
  • [2] Intestinal Clostridium species lower host susceptibility to enterohemorrhagic Escherichia coli O157:H7 infection
    Koyanagi, Yukako
    Suzuki, Rie
    Ihara, Kohei
    Miyagi, Hikaru
    Isogai, Hiroshi
    Yoneyama, Hiroshi
    Isogai, Emiko
    PATHOGENS AND DISEASE, 2019, 77 (04):
  • [3] Incidence of Escherichia coli O157:H7 in Thailand
    Sukhumungoon, Pharanai
    SAINS MALAYSIANA, 2015, 44 (02): : 261 - 267
  • [4] Prediction of pathogenicity islands in Enterohemorrhagic Escherichia coli O157:H7 using genomic barcodes
    Wang, Guoqing
    Zhou, Fengfeng
    Olman, Victor
    Li, Fan
    Xu, Ying
    FEBS LETTERS, 2010, 584 (01) : 194 - 198
  • [5] Treatment options for HUS secondary to Escherichia coli O157:H7
    Bitzan, Martin
    KIDNEY INTERNATIONAL, 2009, 75 : S62 - S66
  • [6] Virulence-related O islands in enterohemorrhagic Escherichia coli O157:H7
    Jiang, Lingyan
    Yang, Wen
    Jiang, Xinlei
    Yao, Ting
    Wang, Lu
    Yang, Bin
    GUT MICROBES, 2021, 13 (01)
  • [7] Interkingdom Chemical Signaling in Enterohemorrhagic Escherichia coli O157:H7
    Kendall, Melissa M.
    MICROBIAL ENDOCRINOLOGY: INTERKINGDOM SIGNALING IN INFECTIOUS DISEASE AND HEALTH, 2ND EDITION, 2016, 874 : 201 - 213
  • [8] PREVALENCE AND CHARACTERIZATION OF SHIGA-TOXIN O157:H7 AND NON-O157:H7 ENTEROHEMORRHAGIC ESCHERICHIA COLI ISOLATED FROM DIFFERENT SOURCES
    Selim, Samy A.
    Ahmed, Salwa F.
    Aziz, Mohamed H. Abdel
    Zakaria, Amira M.
    Klena, John D.
    Pangallo, Domenico
    BIOTECHNOLOGY & BIOTECHNOLOGICAL EQUIPMENT, 2013, 27 (03) : 3834 - 3842
  • [9] After the Fact(or): Posttranscriptional Gene Regulation in Enterohemorrhagic Escherichia coli O157:H7
    Sauder, Amber B.
    Kendall, Melissa M.
    JOURNAL OF BACTERIOLOGY, 2018, 200 (19)
  • [10] Development of a Gold Nanoparticle Vaccine against Enterohemorrhagic Escherichia coli O157:H7
    Sanchez-Villamil, Javier I.
    Tapia, Daniel
    Torres, Alfredo G.
    MBIO, 2019, 10 (04):
12345